参考文献/References:
[1]Cho NH,Shaw JE,Karuranga S,et al.IDF Diabetes Atlas:Global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Research and Clinical Practice,2018,138(6):271-281. [2]Umanath K,Lewis JB.Update on Diabetic Nephropathy: Core Curriculum 2018[J].American Journal of Kidney Diseases,2018,71(6):884-895. [3]Tiwari AK,Kumar DA,Sweeya PS,et al.Vegetables’ juice influences polyol pathway by multiple mechanisms in favour of reducing development of oxidative stress and resultant diabetic complications[J].Pharmacogn Mag,2014,10(Suppl 2):S383-S391． [4]Lagies S,Pichler R,Bork T,et al.Impact of Diabetic Stress Conditions on Renal Cell Metabolome[J].Cells,2019,8(10):1141. [5]ElGamal H,Munusamy S.Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy:Promises and Challenges[J].Protein Pept Lett,2017,24(1):71-77. [6]Shen H,Wang W.Effect of glutathione liposomes on diabetic nephropathy based on oxidative stress and polyol pathway mechanism[J].Journal of Liposome Research,2020,22(3):1-9. [7]Zhou X,Liu Z,Ying K,et al.WJ-39,an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling[J].Oxidative Medicine Andcellular Longevity,2020,2020(4):1-21. [8]Kumar PA,Chitra PS,Reddy GB.Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy[J].Biomolecular Concepts,2016,7(5-6):293-309. [9]Dou L,Jourde-Chiche N.Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease[J].Toxins(Basel),2019,11(10):578. [10]Chawla D,Bansal S,Banerjee BD,et al,Role of advanced glycation end product AGE)-induced receptor(RAGE)expression in diabetic vascular complications[J].Microvasc Res,2014(95):1-6． [11]Jiang W,Li Z,Zhao W,et al.Breviscapine attenuatted contrastmedium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice[J].Am J Transl Res,2016,8(2):329-341. [12]Menne J,Shushakova N,Bartels J,et al.Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy[J].Diabetes,2013,62(4):1167-1174. [13]Yin W,Jiang Y,Xu S,et al.Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon-like peptide-1 on glomeruli and tubules in diabetic rats[J].Journal of Diabetes Investigation,2019,10(3):613-625. [14]DCCT/EDIC Research Group,de Boer IH,Sun W,et al.Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes[J].N Engl J Med,2011,65(25):2366-2376. [15]Singh UK,Arora MK.Oxidative Stress:Meeting Multiple Targets in Pathogenesis of Diabetic Nephropathy[J].Current Drug Targets,2014,15(5):531-538. [16]Suryavanshi SV,Garud MS,Barve K,et al.Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats[J].Pharmacology,2020,105(11-12):1-11. [17]Tutun B,Elbe H,Vardi N,et al.Dexpanthenol reduces diabetic nephropathy and renal oxidative stress in rats[J].Biotechnic and Histochemistry,2018,94(2):1-8. [18]Hasanain M,Bhattacharjee A,Pandey P,et al.α-Solanine induces ROS-mediated autophagy through activation of endoplasmic reticulum stress and inhibition of Akt/mTOR pathway[J].Cell Death&Amp Disease,2015,6(8):e1860. [19]Cao Y,Hao Y,Li H,et al.Role of endoplasmic reticulum stress in apoptosis of differentiated mouse podocytes induced by high glucose[J].International Journal of Molecular Medicine,2014,33(4):809-811. [20]Lee ES,Kim HM,Kang JS,et al.Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model[J].Nephrology Dialysis Transplantation,2016,31(3):391-400. [21]Donate-Correa J,Martín-Núez E,Muros-de-Fuentes M,et al.Inflammatory cytokines in diabetic nephropathy[J].J Diabetes Res,2015(2015):948417. [22]Pérez-Morales RE,Del Pino MD,Valdivielso JM,et al.Inflammation in Diabetic Kidney Disease[J].Nephron,2019,143(1):12-16. [23]Lin J,Cheng A,Cheng K,et al.New Insights into the Mechanisms of Pyroptosis and Implications for Diabetic Kidney Disease[J].Int J Mol Sci,2020,21(19):7057. [24]Alicic RZ,Johnson EJ,Tuttle KR.Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease[J].Adv Chronic Kidney Dis,2018,25(2):181-191. [25]Sansone P,Bromberg J.Targeting the interleukin-6/Jak/stat pathway in human malignancies[J].J Clin Oncol,2012,30(9):1005-1014. [26]García-García PM,Getino-Melián MA,Domínguez-Pimentel V,et al.Inflammation in diabetic kidney disease[J].World J Diabetes,2014,5(4):431-443. [27]陈辛玲,王生兰.细胞自噬过程、通路、调控及其与肺动脉高压的多重相关性[J].中国组织工程研究,2021,25(2):311-316. [28]郭园园.AGEs通过诱导巨噬细胞自噬影响糖尿病创面愈合的机制研究[D].上海交通大学,2016. [29]Prasad A,Lane JR,Tsimikas S,et al.Plasma Levels of Advanced Glycation End Products Are Related to the Clinical Presentation and Angiographic Severity of Symptomatic Lower Extremity Peripheral Arterial Disease[J].Int J Angiol,2016,25(1):44-53. [30]Liu K,Zhao E,Ilyas G,et al.Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization[J].Autophagy,2015,11(2):271-284. [31]Nowak KL,Hopp K.Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential[J].Clin J Am Soc Nephrol,2020,15(4):577-584. [32]Galluzzi L,Bravo-San Pedro JM,Levine B,et al.Pharmacological modulation of autophagy:therapeutic potential and persisting obstacles[J].Nat Rev Drug Discov,2017,16(7):487-511. [33]Lenoir O,Jasiek M,Hénique C,et al.Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis[J].Autophagy,2015,11(7):1130-1145. [34]Takahashi A,Takabatake Y,Kimura T,et al.Autophagy Inhibits the Accumulation of Advanced Glycation End Products by Promoting Lysosomal Biogenesis and Function in the Kidney Proximal Tubules[J].Diabetes,2017,66(5):1359-1372. [35]Liu L,Yang L,Chang B,et al.The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway[J].Renal failure,2018,40(1):492-497. [36]Qiao Y,Gao K,Wang Y,et al.Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway[J].Experimental and Therapeutic Medicine,2017,13(6):3223-3230. [37]Dong D,Fan TT,Ji YS,et al.Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes[J].International Urology and Nephrology,2019,51(4):755-764. [38]史嫣.长链非编码RNA DLX6-AS1/Dlx6-os1在糖尿病肾病患者和糖尿病肾病模型小鼠肾组织中的表达变化及意义[D].郑州大学,2019. [39]许瑶,娄静,赵峰.LncRNA-XIST/miR-137/Notch1在糖尿病视网膜病变患者血清和玻璃体中的表达及机制[J].实用医学杂志,2020,36(17):2409-2414. [40]Lv LL,Feng Y,Wu M,et al.Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury[J].Cell Death& Differentiation,2020,27(1):210-226. [41]Liu F,Zhang ZP,Xin GD,et al.miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1[J].European Review for Medical and Pharmacological Sciences,2018,22(13):4252-4260. [42]Barutta F,Tricarico M,Corbelli A,et al.Urinary exosomal microRNAs in incipient diabetic nephropathy[J].PloS One,2013,8(11):e73798. [43]Eissa S,Matboli M,Aboushahba R,et al.Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease[J].Journal of Diabetes and Its Complications,2016,30(8):1585-1592.
相似文献/References:
[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Medical Information,2018,31(07):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Medical Information,2018,31(07):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Medical Information,2018,31(07):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Medical Information,2018,31(07):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者
血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with
Type 2 Diabetic Nephropathy[J].Medical Information,2018,31(07):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Medical Information,2019,32(07):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[7]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Medical Information,2018,31(07):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[8]朱晓晓,张 顺,蔡 挺.镍暴露相关的肺癌发生分子机制研究[J].医学信息,2018,31(17):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
ZHU Xiao-xiao,ZHANG Shun,CAI Ting.Molecular Mechanism of Lung Cancer Related to Nickel Exposure[J].Medical Information,2018,31(07):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
[9]潘建伟,虞 琳.人巨细胞病毒感染与细胞自噬的关系[J].医学信息,2018,31(18):26.[doi:10.3969/j.issn.1006-1959.2018.18.010]
PAN Jian-wei,YU Lin.Relationship between Human Cytomegalovirus Infection and Autophagy[J].Medical Information,2018,31(07):26.[doi:10.3969/j.issn.1006-1959.2018.18.010]
[10]邵 磊,赵春燕,王贤良.自噬信号通路在冠脉支架后血管狭窄中的研究进展[J].医学信息,2018,31(21):28.[doi:10.3969/j.issn.1006-1959.2018.21.009]
SHAO Lei,ZHAO Chun-yan,WANG Xian-liang.Progress of the Research on Autophagy Signal Pathway in Coronary Artery Stenosis after Stent[J].Medical Information,2018,31(07):28.[doi:10.3969/j.issn.1006-1959.2018.21.009]
[11]陈 婷,刘金彦.PI3K/Akt/mTOR通路与足细胞自噬在糖尿病肾病肾功能修复中的研究[J].医学信息,2022,35(22):170.[doi:10.3969/j.issn.1006-1959.2022.22.042]
CHEN Ting,LIU Jin-yan.The study of PI3K/Akt/mTOR Pathway and Podocyte Autophagy in Renal Function Repair of Diabetic Nephropathy[J].Medical Information,2022,35(07):170.[doi:10.3969/j.issn.1006-1959.2022.22.042]